Foghorn Therapeutics Inc. Contracts & Agreements

45 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Foghorn Therapeutics Inc. 2016 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Foghorn Therapeutics Inc.
Biotechnology
CA
2020
Letter Agreement between Foghorn Therapeutics Inc. and Anna Rivkin, dated July 18, 2024
Foghorn Therapeutics Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Foghorn Therapeutics Inc.
2024
Underwriting Agreement dated May 20, 2024, by and among Foghorn Therapeutics Inc. and Jefferies LLC, TD Securities (USA) LLC and Evercore Group L.L.C, as representatives of the...
Underwriting Agreements
Foghorn Therapeutics Inc.
2024
[Remainder of Page Intentionally Left Blank]
Foghorn Therapeutics Inc.
2024
Consulting Agreement between Foghorn Therapeutics Inc. and Ian F. Smith, dated as of December 8, 2023
Consulting Agreements
Foghorn Therapeutics Inc.
2024
Letter Agreement between Foghorn Therapeutics Inc. and Alfonso Quints Cardama, M.D., dated August 4, 2023
Foghorn Therapeutics Inc.
2023
Form of Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement for use between Foghorn Therapeutics Inc. and its executive officers, updated July 2022
Non-Competition Agreements
Foghorn Therapeutics Inc.
Biotechnology
MA
2022
Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Carlos Costa, dated July 15, 2022
Foghorn Therapeutics Inc.
2022
First Amendment to Lease by and between ARE-Tech Square, LLC and Foghorn Therapeutics Inc. dated June 29, 2020
Lease Agreements
Foghorn Therapeutics Inc.
Biotechnology
2022
Sales Agreement, dated as of April 15, 2022, by and between Foghorn Therapeutics Inc. and Cowen and Company, LLC
Sales Agreements
Foghorn Therapeutics Inc.
2022
Stock Purchase Agreement, dated as of December 10, 2021, between Foghorn Therapeutics Inc. and Eli Lilly and Company
Stock Agreements
Foghorn Therapeutics Inc.
Biotechnology
DE
2021
Amendment to Amended and Restated Investors Rights Agreement, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of December 10, 2021
Investor Rights Agreements
Foghorn Therapeutics Inc.
2021
Consulting Agreement by and Between Ian F. Smith and Foghorn Therapeutics Inc., dated as of June 23, 2021
Consulting Agreements
Foghorn Therapeutics Inc.
2021
First Amendment to Loan and Security Agreement dated as of June 14, 2021, among Oxford Finance LLC and Foghorn Therapeutics Inc
Loan Agreements
Foghorn Therapeutics Inc.
Biotechnology
2021
Amendment to Consulting Agreement between Foghorn Therapeutics Inc. and Cigall Kadoch dated October 29, 2020
Consulting Agreements
Foghorn Therapeutics Inc.
Biotechnology
2021
Description of Registrants Securities
Foghorn Therapeutics Inc.
2021
Loan and Security Agreement dated as of November 19, 2020, among Oxford Finance LLC, and Foghorn Therapeutics Inc
Loan Agreements
Foghorn Therapeutics Inc.
Biotechnology
NY
2020
Form of Warrant to Purchase Common Stock of Foghorn Therapeutics Inc., dated as of November 19, 2020
Warrant Agreements
Foghorn Therapeutics Inc.
Biotechnology
NY
2020
Form of Non-Statutory Stock Option Agreement (Employees) under the Foghorn Therapeutics Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Foghorn Therapeutics Inc.
2020
Consulting Agreement between Foghorn Therapeutics Inc. and Cigall Kadoch, dated October 1, 2015
Consulting Agreements
Foghorn Therapeutics Inc.
Biotechnology
MA
2020
Foghorn Therapeutics Inc. 2020 Cash Incentive Plan
Bonus & Incentive Agreements
Foghorn Therapeutics Inc.
Biotechnology
MA
2020
Foghorn Therapeutics Inc. 2020 Employee Stock Purchase Plan
Stock Agreements
Foghorn Therapeutics Inc.
2020
Form of Non-Statutory Stock Option Agreement (Non-Employee Directors) under the Foghorn Therapeutics Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Foghorn Therapeutics Inc.
2020
Form of Incentive Stock Option Agreement under the Foghorn Therapeutics Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Foghorn Therapeutics Inc.
Biotechnology
2020
Foghorn Therapeutics Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Foghorn Therapeutics Inc.
Biotechnology
DE
2020
Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Carl P. Decicco, Ph.D., dated October 14
Foghorn Therapeutics Inc.
Biotechnology
MA
2020
Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Samuel Agresta, M.D., M.P.H. & T.M., dated October 14
Foghorn Therapeutics Inc.
2020
Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Adrian Gottschalk, dated October 14, 2020
Foghorn Therapeutics Inc.
Biotechnology
MA
2020
Amended and Restated Investors Rights Agreement, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of December 18, 2018
Investor Rights Agreements
Foghorn Therapeutics Inc.
Biotechnology
DE
2020
Specimen stock certificate evidencing shares of common stock
Stock Agreements
Foghorn Therapeutics Inc.
Biotechnology
2020
Form of Underwriting Agreement
Underwriting Agreements
Foghorn Therapeutics Inc.
2020
Amendment to the Investors Rights Agreement and the Voting Agreement, dated December 18, 2018, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of...
Voting Agreements
Foghorn Therapeutics Inc.
2020
Amended and Restated Investors Rights Agreement, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of December 18, 2018
Investor Rights Agreements
Foghorn Therapeutics Inc.
2020
Form of Warrant to Purchase Series A-2 Preferred Stock of the Registrant issued to Silicon Valley Bank, dated November 29, 2016
Warrant Agreements
Foghorn Therapeutics Inc.
Biotechnology
CA
2020
Lease Agreement by and between ARE-MA Region No. 45, LLC and Foghorn Therapeutics Inc., dated August 24, 2017
Lease Agreements
Foghorn Therapeutics Inc.
2020
Lease Agreement by and between ARE-Tech Square, LLC and Foghorn Therapeutics Inc., dated October 23, 2019
Lease Agreements
Foghorn Therapeutics Inc.
2020
Exclusive Collaboration and License Agreement, by and between Merck Sharp & Dohme Corp. and Foghorn Therapeutics Inc., dated as of July 2, 2020
Collaboration Agreements
Foghorn Therapeutics Inc.
2020
Form of Stock Restriction Agreement under the Foghorn Therapeutics Inc. 2016 Stock Incentive Plan
Bonus & Incentive Agreements
Foghorn Therapeutics Inc.
Biotechnology
MA
2020
Form of Incentive Stock Option Grant Notice under the Foghorn Therapeutics Inc. 2016 Stock Incentive Plan
Bonus & Incentive Agreements
Foghorn Therapeutics Inc.
Biotechnology
2020
Form of Non-Qualified Stock Option Grant Notice under the Foghorn Therapeutics Inc. 2016 Stock Incentive Plan
Bonus & Incentive Agreements
Foghorn Therapeutics Inc.
2020
Form of Indemnification Agreement between Foghorn Therapeutics Inc. and its directors and officers
Indemnification Agreements
Foghorn Therapeutics Inc.
Biotechnology
DE
2020
Letter Agreement between Foghorn Therapeutics Inc. and Adrian Gottschalk, dated April 20, 2017
Foghorn Therapeutics Inc.
Biotechnology
2020
Letter Agreement between Foghorn Therapeutics Inc. and Samuel Agresta, M.D., M.P.H. & T.M., dated July 11, 2019
Foghorn Therapeutics Inc.
2020
Letter Agreement between Foghorn Therapeutics Inc. and Carl P. Decicco, Ph.D., dated December 5, 2018
Foghorn Therapeutics Inc.
Biotechnology
2020